drugset
drugset / Trial / NCT02459938

Safety and Efficacy of ZP-Glucagon to Injectable Glucagon for Hypoglycemia

NCT02459938 ↗

Phase 1 Completed 16 enrolled Zosano Pharma Corporation
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to determine whether glucagon administered by microneedle patch is comparable to glucagon administered by injection pen in the treatment of insulin-induced hypoglycemia.

Timeline

Start
2015-01
Primary completion
2015-08
Completion
2015-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Glucagon Peptide 0.5 mg Other
Comparator Glucagon Peptide 0.5 mg Subcutaneous
Comparator Glucagon Peptide 1 mg Other
Comparator Glucagon Peptide 1 mg Subcutaneous

Indications

hypoglycemia